Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
- PMID: 31803700
- PMCID: PMC6877719
- DOI: 10.3389/fped.2019.00481
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
Abstract
Severe Combined Immunodeficiencies (SCID) are a heterogeneous group of monogenetic diseases. We describe the typical clinical presentation of patients with SCID as well as basic principles in diagnosis and therapy by hematopoietic stem cell transplantation. Therapeutic strategies may differ between subtypes and the inherent reduced capacity or inablility to reject a graft have to be considered.
Keywords: HSCT; SCID; clinical presentation; hematopoietic stem cell transplantation; infections; severe combined immunodeficiency.
Copyright © 2019 Haddad and Hoenig.
References
-
- Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, et al. . Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol. (2014) 133:1092–8. 10.1016/j.jaci.2013.09.044 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
